NovaBridge Biosciences's total assets for Q4 2025 were ¥37.24M, a decrease of -98.11% from the previous quarter. NBP total liabilities were ¥4.23M for the fiscal quarter, a -96.79% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.